International Patent: METHODS AND COMPOSITIONS RELATED TO ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ADCS) THAT BIND SLC34A2 PROTEINS

GENEVA, Sept. 24 -- ADCENTRX THERAPEUTICS INC. filed a patent application (US2026/019687) for “METHODS AND COMPOSITIONS RELATED TO ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ADCS) THAT BIND SLC34A2 PROTEINS”. With publication no. WO/2026/198631, here are the other details related to the patent application:

Kind: Initial Publication without ISR [A2]

IPC: C07K 16/28

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....